Live Breaking News & Updates on Efficiency In Health Care

Stay updated with breaking news from Efficiency in health care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aflibercept in AMD: no proof of added benefit

Manufacturer's dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG)… ....

Efficiency In Health Care , German Institute For Quality , Medicinal Products , German Institute , Health Care , Federal Joint Committee ,